Perceptive Capital Solutions Corp

Perceptive Capital Solutions Corp (Nasdaq: PCSC) is a special purpose acquisition company sponsored by Perceptive Advisors, a New York-based investment firm with an established track record in healthcare and life sciences investing. PCSC completed its initial public offering in 2021, targeting the biopharmaceutical and broader healthcare sector for a business combination. In May 2026, the company filed a definitive proxy statement with the SEC — a DEF 14A dated May 14, 2026 under accession number 0001140361-26-021304 — indicating an active shareholder vote process is underway. For complete filing history, deal status timelines, and comparable SPAC transaction data, sign up for a SpacDesk account at SpacDesk.com.